Displaying drugs 1476 - 1500 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Zuclopenthixol | 400.965 C22H25ClN2OS |  | An antipsychotic indicated for the management of schizophrenia. The acuphase formulation is indicated for initial treatment of acute psychosis or exacerbation of psychosis, while the depot formulation is best for maintenance. | Thioxanthene Derivatives |
| Ertugliflozin | 436.89 C22H25ClO7 |  | An SGLT2 inhibitor used to treat type 2 diabetes mellitus alone or in combination with other antidiabetic drugs. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Nebivolol | 405.435 C22H25F2NO4 |  | A beta blocking agent used to treat hypertension and aid in the management of heart failure. | Antihypertensive Agents / Beta blocking agents and calcium channel blockers / Beta Blocking Agents, Selective / Beta Blocking Agents, Selective, and Thiazides |
| Trimethaphan | 365.512 C22H25N2OS |  | For the controlled reduction of blood pressure during surgery and in the treatment of hypertensive emergencies. | Sulfonium Derivatives |
| Indoramin | 347.4534 C22H25N3O |  | Indoramin is a discontinued piperidine antiadrenergic drug with the trade names Baratol and Doralese. It is a selective alpha-1 adrenergic antagonist with no reflex tachycardia and direct myocardial depression action. | Adrenergic alpha-Antagonists |
| Moricizine | 427.517 C22H25N3O4S |  | An antiarrhythmic used to treat arrhythmias. | Neurotoxic agents |
| Ertapenem | 475.515 C22H25N3O7S |  | A carbapenem antibiotic used for the treatment of moderate to severe infections caused by susceptible bacteria. | Anti-Bacterial Agents / Carbapenems / Penem Antibacterial |
| Colchicine | 399.443 C22H25NO6 |  | An alkaloid used to treat gout and Familial Mediterranean Fever as well as prevent major cardiovascular events. | Preparations With No Effect on Uric Acid Metabolism |
| Clobetasone | 408.89 C22H26ClFO4 |  | A corticosteroid used to treat dry eyes, eczema, and dermatitis. | Corticosteroids, Moderately Potent (Group II) |
| Dasatinib | 488.006 C22H26ClN7O2S |  | A tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia. | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Fluphenazine | 437.522 C22H26F3N3OS |  | A phenothiazine used to treat patients requiring long-term neuroleptic therapy. | Phenothiazines With Piperazine Structure |
| Eletriptan | 382.519 C22H26N2O2S |  | A triptan used for the treatment of migraines. | Selective Serotonin 5-HT1 Receptor Agonists / Serotonin Receptor Agonists |
| Diltiazem | 414.518 C22H26N2O4S |  | A calcium channel blocker used to treat hypertension and to manage chronic stable angina. | Benzothiazepine Derivatives |
| Clidinium | 352.4467 C22H26NO3 |  | A synthetic anticholinergic used to treat peptic ulcer disease, colicky abdominal pain, diverticulitis, and IBS. | Agents producing tachycardia |
| Ulobetasol | 428.9 C22H27ClF2O4 |  | A lipocortin corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses. | Corticosteroids, Potent (Group III) |
| Encorafenib | 540.01 C22H27ClFN7O4S |  | A kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Fluticasone | 444.51 C22H27F3O4S |  | A corticosteroid indicated in the treatment of corticosteroid responsive dermatoses, asthma, and COPD. | Corticosteroids, Potent (Group III) / Glucocorticoids |
| Sunitinib | 398.4738 C22H27FN4O2 |  | A receptor tyrosine kinase inhibitor and chemotherapeutic agent used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). | Protein Kinase Inhibitors |
| Danazol | 337.4553 C22H27NO2 |  | A synthetic steroid and pituitary gonadotropin inhibitor used in the treatment of endometriosis and symptomatic treatment of severe pain and tenderness associated with benign fibrocystic breasts. | Antigonadotropins and Similar Agents |
| Clobetasol | 410.907 C22H28ClFO4 |  | Clobetasol is under investigation for the treatment of Scleroderma. Clobetasol has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids. | Corticosteroids, Very Potent (Group IV) |
| Clocortolone | 410.907 C22H28ClFO4 |  | A corticosteroid used to treat inflammatory and pruritic dermatoses of the scalp. | Corticosteroids, Moderately Potent (Group II) |
| Difluocortolone | 394.459 C22H28F2O4 |  | A topical corticosteroid used for the symptomatic treatment of inflammatory skin disorders like eczema, seborrheic eczema, lichen planus and psoriasis. | Corticosteroids, Potent (Group III) |
| Flumethasone | 410.458 C22H28F2O5 |  | A corticosteroid used to treat contact dermatitis, atopic dermatitis, eczema, psoriasis, diaper rash, and other skin conditions. | Corticosteroids, Moderately Potent (Group II) |
| Diflorasone | 410.4515 C22H28F2O5 |  | A topical corticosteroid used to treat the symptoms of various inflammatory skin conditions that cause erythema, pruritus, and discomfort. | Corticosteroids, Potent (Group III) |
| Rosuvastatin | 481.538 C22H28FN3O6S |  | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. | Sulfonamides |
Displaying drugs 1476 - 1500 of 2774 in total